St. Augustine, Florida-based Flagler Health+ and Birmingham, Alabama-based Andrews Sports Medicine, LLC are joining forces to bring Andrews Sports Medicine to Northeast Florida.
Andrews Sports Medicine Is Coming to Florida
The organizations have entered into an affiliation agreement. One of the initial projects for the partnership is the creation of an orthopedics-focused surgery center at the Flagler Health+ campus located in Durbin Park in St Johns, Florida. Per the press release, the master affiliation agreement includes other opportunities including “orthopedic research and education, sports medicine clinics, rehabilitation centers, school-based programs and more.”
Founded by orthopedic surgeon Jim Andrews, M.D., Andrews Sports Medicine provides orthopedic and sports medicine care. Dr. Andrews is well-known in the sports medicine industry. He has provided orthopedic care for notable sports teams and high-profile athletes from across the U.S.
Flagler Health+, an extension of Flagler Hospital, is a “total-care enterprise” focused on enhancing the health of Northeast Florida communities. In February 2020, it began its orthopedic specialists practice which has Florida locations in Palm Coast, St. Augustine, and Ponte Vedra. This fall Flagler Health+ will continue its development of the Durbin Park campus. This includes a health village and an ambulatory surgery center.
OTW spoke with Flagler Health+ President and CEO Jason Barrett about the organizations’ decision to partner. Barrett told OTW, “Jim Andrews has a vision for reimagining orthopedic care. At Flagler Health+, we are committed to delivering patient-centered care that is all inclusive, contemplating physical, social and economic health. It was clear that the values and mission of our two organizations align completely.”
Barrett also discussed the organizations’ goals for the remainder of the year. Barrett explained to OTW, “Our goal for the remainder of the year is to finalize planning for building the Andrews Sports Medicine Center on our Durbin Park, Florida campus and crystallize further opportunities to innovate together.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.